COMP <GO>
SIBN vs KIDS // EV/EBITDA & P/E VALUATION
SI-BONE Inc. (NASDAQ) VS. OrthoPediatrics Corp. (NASDAQ) • 15-METRIC TALLY: SIBN 8
— KIDS 2
■ METRIC PARITY
LAST: $22.41 (+2.66%) • MKT CAP: $1.00B
valuation
—
LAST: $31.52 (+2.34%) • MKT CAP: $823.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIBN VS. KIDS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SIBN | KIDS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | 73.10% | +6.50 | SIBN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.30% | -7.30% | -3.00 | KIDS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.90% | -1.94% | +1.04 | SIBN | /fcf-yield <GO> |
| Operating Margin | -11.10% | -16.60% | +5.50 | SIBN | /operating-margins <GO> |
| Net Profit Margin | -9.40% | -16.80% | +7.40 | SIBN | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 15.40% | +4.80 | SIBN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.73 | 3.00 | +5.73 | SIBN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | SIBN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.6 | 77.8 | -19.16 | KIDS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.00B | $823.0M | $181.4M | SIBN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SIBN REV | KIDS REV | SIBN GROSS % | KIDS GROSS % | SIBN FCF | KIDS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $200.9M | $236.3M | 79.6% | 73.1% | -$9.1M | -$16.0M |
| FY 2024 | $167.2M | $204.7M | 79.0% | 72.6% | -$22.9M | -$41.3M |
| FY 2023 | $138.9M | $148.7M | — | — | -$18.7M | -$27.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIBN // BETA —
KIDS // BETA —